Andrew Lukowiak

Andrew Lukowiak

Corporate Officer/Principal chez NEOGENOMICS, INC.
54 ans
Health Technology
Health Services
Consumer Services

Profil

Dr. Andrew A. Lukowiak is a Chief Innovation Officer at NeoGenomics, Inc. and a President & Director at New Millennium Holdco, Inc. He is on the Board of Directors at New Millennium Holdco, Inc. Dr. Lukowiak was previously employed as a President & Chief Scientific Officer by Talis Biomedical Corp., a President & Chief Scientific Officer by Epigenomics AG, a Chief Executive Officer by Millennium Health LLC, and a Chief Operating Officer by AltheaDx, Inc. He also served on the board at Biocom, Inc. He received his undergraduate degree from The Pennsylvania State University and a doctorate degree from the University of Georgia.

Postes actifs de Andrew Lukowiak

SociétésPosteDébut
NEOGENOMICS, INC. Corporate Officer/Principal 01/09/2024
President -

Anciens postes connus de Andrew Lukowiak

SociétésPosteFin
TALIS BIOMEDICAL CORPORATION President 14/01/2024
EPIGENOMICS AG President 31/05/2023
Directeur Général 26/10/2021
ALTHEADX INC Directeur des opérations -
Directeur/Membre du Conseil -
Voir l'expérience en détail de Andrew Lukowiak

Formation de Andrew Lukowiak

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

8

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Services

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Andrew Lukowiak
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT